As documented previously, OIP5-AS1 may act as a ceRNA to combine with HuR, thereby inhibiting the expression of HuR to participate in the phenotypic regulation of tumor cells [12], and lncRNA is increasingly identified as expressed aberrantly in tumors. The gene discussed is OIP5; the disease is neoplasm.